| Item type |
文献 / Documents(1) |
| 公開日 |
2025-04-15 |
| アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 出版社版DOI |
|
|
|
関連識別子 |
https://doi.org/10.3389/fcvm.2024.1377228 |
|
|
関連名称 |
10.3389/fcvm.2024.1377228 |
| 出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| タイトル |
|
|
タイトル |
Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan |
| 著者 |
川田, 敬
Ishida, Tomoaki
Fukuda, Hitoshi
Hyohdoh, Yuki
Kubo, Toru
Hamada, Tomoyuki
Baba, Yuichi
Hayashi, Toshinobu
相澤, 風花
八木, 健太
(井澤)石澤, 有紀
新村, 貴博
阿部, 真治
合田, 光寛
Kitaoka, Hiroaki
石澤, 啓介
|
| 抄録 |
|
|
内容記述 |
Introduction: Guideline-directed medical therapy with renin-angiotensin system (RAS) inhibitors and beta-blockers has improved the survival of patients with heart failure (HF) and reduced left ventricular ejection fraction (HFrEF). However, it is unclear whether RAS inhibitors and beta-blockers can be administered to older patients with HF. Therefore, this study aimed to investigate the effects of beta-blockers and RAS inhibitors on the prognosis of older patients with HFrEF.
Methods: Demographic, clinical, and pharmacological data from 1,061 patients with acute decompensated HF, enrolled in the Kochi Registry of Subjects with Acute Decompensated Heart Failure (Kochi YOSACOI study), were analyzed to assess their impact on mortality. Additionally, a machine learning approach was applied to complement the conventional statistical model for analysis. Patients with HFrEF (n = 314) were divided into the all-cause mortality within 2 years group (n = 80) and the survivor group (n = 234).
Results: Overall, 41.1% (129/314) of the patients were aged ≥80, and 25.5% (80/314) experienced all-cause mortality within 2 years. Furthermore, 57.6% (181/314) and 79.0% (248/314) were prescribed RAS inhibitors and beta-blockers, respectively. Our analysis showed that RAS inhibitor use was associated with reduced all-cause mortality and cardiac death in patients with HFrEF of all ages (P < 0.001), and beta-blocker use had an interaction with age. Machine learning revealed that the use of beta-blockers altered the risk of mortality, with a threshold of approximately 80 years of age. Beta-blocker use was associated with lower all-cause mortality and cardiac death in patients with HFrEF aged <80 years (P < 0.001) but not in those aged ≥80 years (P = 0.319 and P = 0.246, respectively). These results suggest that beta blockers may differ in their all-cause mortality benefits according to age.
Conclusions: RAS inhibitors prevented all-cause mortality and cardiac death at all ages, whereas beta-blockers had different effects depending on the patient's age. This study suggested that the choice of beta-blockers and RAS inhibitors is more important in older patients with HFrEF than in younger patients with the same condition. |
| キーワード |
|
|
主題 |
heart failure |
| キーワード |
|
|
主題 |
medications |
| キーワード |
|
|
主題 |
beta-blockers |
| キーワード |
|
|
主題 |
angiotensin-converting enzyme inhibitors |
| キーワード |
|
|
主題 |
angiotensin II receptor blockers |
| キーワード |
|
|
主題 |
heart failure with reduced left ventricular ejection fraction |
| キーワード |
|
|
主題 |
older patients with heart failure |
| 書誌情報 |
en : Frontiers in Cardiovascular Medicine
巻 11,
p. 1377228,
発行日 2024-05-31
|
| 収録物ID |
|
|
収録物識別子タイプ |
EISSN |
|
収録物識別子 |
2297055X |
| 出版者 |
|
|
出版者 |
Frontiers Media SA |
| 権利情報 |
|
|
権利情報 |
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| EID |
|
|
識別子 |
409654 |
| 言語 |
|
|
言語 |
eng |
fcvm_11_1377228.pdf (2.3 MB)
.png)
